Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, mainly due to its late diagnosis and lack of effective therapies, translating into a low 5-year 12% survival rate, desp...
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Emilia Alors-P érez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, María Trinidad Moreno-Montilla, Víctor García-Vioque, Inmaculada Berbel, Raúl M. Luque, Bruno Sainz Jr, Alejandro Ibáñez-Costa and Justo P. Castaño Tags: Review Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Trinidad and Tobago Health